Skip to main content

Peer Review reports

From: The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled study

Original Submission
12 Mar 2022 Submitted Original manuscript
17 Apr 2022 Reviewed Reviewer Report
18 Apr 2022 Reviewed Reviewer Report
19 May 2022 Author responded Author comments - Fude Yang
Resubmission - Version 2
19 May 2022 Submitted Manuscript version 2
25 May 2022 Author responded Author comments - Fude Yang
Resubmission - Version 3
25 May 2022 Submitted Manuscript version 3
26 May 2022 Author responded Author comments - Fude Yang
Resubmission - Version 4
26 May 2022 Submitted Manuscript version 4
1 Jun 2022 Reviewed Reviewer Report
10 Jul 2022 Reviewed Reviewer Report
26 Jul 2022 Author responded Author comments - Fude Yang
Resubmission - Version 5
26 Jul 2022 Submitted Manuscript version 5
27 Jul 2022 Author responded Author comments - Fude Yang
Resubmission - Version 6
27 Jul 2022 Submitted Manuscript version 6
5 Oct 2022 Reviewed Reviewer Report
7 Dec 2022 Author responded Author comments - Fude Yang
Resubmission - Version 7
7 Dec 2022 Submitted Manuscript version 7
15 Dec 2022 Reviewed Reviewer Report
22 Jan 2023 Author responded Author comments - Fude Yang
Resubmission - Version 8
22 Jan 2023 Submitted Manuscript version 8
25 Jan 2023 Author responded Author comments - Fude Yang
Resubmission - Version 9
25 Jan 2023 Submitted Manuscript version 9
31 Jan 2023 Reviewed Reviewer Report
Resubmission - Version 10
Submitted Manuscript version 10
Publishing
3 Feb 2023 Editorially accepted
15 Mar 2023 Article published 10.1186/s12888-023-04588-0

You can find further information about peer review here.

Back to article page